Sebaloxavir marboxil clinical trials
Also written ZX-7101A.
How each study uses sebaloxavir marboxil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the sebaloxavir marboxil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2023 (4)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
Nanjing Zenshine Pharmaceuticals (8)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses sebaloxavir marboxil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Study to Assess the Prophylactic Efficacy and Safety of Sebaloxavir Marboxil Tablets/Oral Suspension for Influenza Prevention in Household Contacts Aged ≥2 Years.Not yet recruitingPhase 3Nanjing Zenshine PharmaceuticalsNCT07730346Written as Sebaloxavir marboxil
- Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With InfluenzaTerminatedPhase 3Nanjing Zenshine PharmaceuticalsNCT06669351Written as ZX-7101A
- Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents with InfluenzaCompletedPhase 3Nanjing Zenshine PharmaceuticalsNCT06099873Written as ZX-7101A
- A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated InfluenzaCompletedPhase 2/3Nanjing Zenshine PharmaceuticalsNCT05702489Written as ZX-7101A
- A Study to Assess the Effect of Itraconazole Capsules on the Pharmacokinetics of ZX-7101A Tablets in Healthy Adult Subjects in ChinaCompletedPhase 1Nanjing Zenshine PharmaceuticalsNCT05949385Written as ZX-7101A
- A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy SubjectsCompletedPhase 1Nanjing Zenshine PharmaceuticalsNCT05955027Written as ZX-7101A
- A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult SubjectsCompletedPhase 1Nanjing Zenshine PharmaceuticalsNCT06057103Written as ZX-7101A
- Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy VolunteersCompletedPhase 1Nanjing Zenshine PharmaceuticalsNCT05217732Written as ZX-7101A
Codes
What other systems call sebaloxavir marboxil · ClinicalTrials.gg INT017363
- UNII (FDA) N89ENH3CTUSEBALOXAVIR MARBOXILOne source FDA
- NCI Thesaurus C223304Sebaloxavir MarboxilOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | N89ENH3CTU | SEBALOXAVIR MARBOXIL | One source FDA |
| NCI Thesaurus | C223304 | Sebaloxavir Marboxil | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.